ABSTRACT-We reported previously that serotonin (5-HT) transport was attenuated by treatment of platelets with EGTA, and that this inhibitory effect of EGTA was restored by CaC12. In the present study, the inhibitory effect of EGTA was found to be uncompetitive, and no inhibitory effect was observed when EGTA was added at 20'C. Genistein and thyrphostin A47, both protein tyrosine kinase inhibitors, inhibited Ca 2+-induced restoration of 5-HT transport. In contrast, the protein tyrosine phosphatase inhibitor phenylarsine oxide significantly augmented Ca2+-induced restoration of 5-HT transport. These results might support the hypothesis that the glycoprotein (GP) IIb/IIIa complex, a platelet membrane integrin protein, might regulate 5-HT transport into blood platelets. It is conceivable that Ca 2+ chelation by EGTA might cause temperature-dependent dissociation of the GP IIb/IIIa complex, which results in the reduction of 5-HT transport. Rearrangement of the GP IIb/IIIa complex by replenishment of the Ca 2+ binding sites might restore the EGTA-induced reduction of 5-HT transport.
Blood platelets have a very rapid and active transport system for serotonin (5-HT), which has been shown to have the same pharmacological characteristics as serotonergic nerve endings (1). They have been proposed as a potential model for 5-HT nerve terminals. However, physiological regulation of this neurotransmitter transport into blood platelets as well as into nerve terminals has not been clearly demonstrated (2).
In our previous study, we reported that 5-HT transport activity into blood platelets was attenuated by the treatment of platelet-rich plasma with 1 mM EGTA, an extracellular Ca 2+ chelator, and that this inhibitory effect of EGTA was ameliorated by the application of 2 mM CaC12 (3). It was suggested that depletion of Ca 2+ storage sites by EGTA would result in the inhibition of 5-HT transport into blood platelets. We postulated that Ca 2+ storage sites in the glycoprotein IIb/IIIa (GP IIb/IIIa) complex, an integrin glycoprotein, might be depleted by EGTA treatment (3). Furthermore, it was demonstrated that concanavalin A (Con A), a lectin from Canavalia ensiformis, inhibits 5-HT transport activity into rabbit blood platelets by affecting intracellular Ca 21 mobilization (4). This effect of Con A was suggested to be initiated by its binding to the membrane surface glycoproteins of blood platelets. The GP IIb/IIIa complex is regarded to be the major platelet surface glycoprotein recognized by the lectin Con A, and it represents more than 50070 of the retained material when platelet lysate is loaded onto a Con A-Sepharose affinity column (5) . These experimental results strongly suggest that GP IIb/IIIa might act as a regulator of 5-HT transport into blood platelets. In the present study, we investigated the possibility that extracellular EGTA and Ca 21 might regulate 5-HT transport activity into platelets through the function of the GP IIb/IIIa complex. Whole blood collected from rabbits (Shimizu Biomaterials, Kyoto) was mixed with 1 / 10 volume of 3.807o sodium citrate and centrifuged at 150 x g for 20 min at room temperature. The supernatant (platelet-rich plasma) was collected and diluted with buffered salt solution (134 mM NaCl, 3 mM MgC12, 5 MM D-glucose, 15 mM Tris-HC1 buffer; pH 7.4) to make diluted platelet-rich plasma (1-2 x 108 platelets/ml). Transport of 3H-5-HT (1098.9 GBq/mmol; NEN Research Products, Boston, MA, USA) into the platelets was determined by the previously described method (6) . The transport activity was expressed as 076 activity relative to that in the control experiments. The mean activity of 3H-5-HT uptake in the Effects of various reagents on the EGTA-induced inhibition of 5-HT transport were estimated by incubating diluted platelet-rich plasma with 1 mM EGTA for 60 min at 37C in the absence or presence of the various tested reagents. Kinetic analysis of the EGTA-induced inhibition of 5-HT transport was performed by using different concentrations of 3H-5-HT (0.1 to 1 tiM) as a substrate; the activity was analyzed by double reciprocal plots (Lineweaver-Burk plots). Effects of various reagents on the Ca2+-induced restoration of 5-HT transport were estimated by incubating EGTA-treated blood platelets with z mM CaC12 for 45 min at 371C in the absence or presence of the various tested reagents. The activity of Ca2+-induced restoration was expressed as ° of the control activity increased by 2 mM CaC12. Genistein and tyrphostine 47 were purchased from Research Biochem. Int. (Natick, MA, USA). Phenylarsine oxide (PAO) was obtained from Sigma Chemical (St. Louis, MO, USA).
In the present study, we confirmed that 3H-5-HT transport activity was reduced to ca. 50% of the control value after incubation of platelets with 1 mM EGTA for 60 min at 37C. Figure 1 shows double reciprocal plots (Lineweaver-Burk plots) of the 5-HT transport activity into platelets in the absence or presence of 1 mM EGTA. In the absence of 1 mM EGTA, the apparent Km value estimated from the X-axis and the Vmax value estimated from the Y-axis were calculated as 1.84 pM and 4.09 nmol/ 109 platelets/3 min, respectively. When the platelets were treated with 1 mM EGTA for 60 min at 37C, both Km and Vmax values were decreased (0.34 pM and 0.74 nmol/ 109 platelets/3 min, respectively). This indicates that the EGTA-induced inhibition of 5-HT transport activity is not derived from competition with substrate recognition sites within the 5-HT transporter, but from its action on some EGTA-sensitive component(s) in the platelets. We suggested previously (3) that depletion of Ca 21 pools induced by EGTA might trigger the inhibitory effect of 5-HT transport activity into blood platelets and postulated that Ca 2+ binding sites within the GP IIb/IIIa complex as well as intracellular Ca 21 storage sites might serve as the EGTA-sensitive Ca 2+ pools responsible for 5-HT transport inhibition.
The heterodimeric GP IIb/IIIa complex serves as the receptor for fibrinogen and other adhesive proteins after platelet activation. Integrity of Ca2+ storage sites in the extracellular domain of the GP IIb/IIIa complex is essential for its fibrinogen recognition site function, and chelation of Ca2+ in the store causes functional inhibition of GP IIb/IIIa (7). In the present study, we examined the possibility that regulation of 5-HT transport by EGTA and/or Ca 21 might be achieved Fig. 3 . Effects of genistein, tyrphostine A47 and phenylarsine oxide (PAO) on 3H-5-HT transport into blood platelets in the absence (a) and in the presence of EGTA (b) and on the Cat+-induced increase in 3H-5-HT transport into EGTA-treated blood platelets (c). a: Diluted platelet-rich plasma was incubated with each drug for 45 min at 371C and 3H-5-HT uptake activity was estimated. 3H-5-HT uptake activity is expressed as % of the control. b: Diluted platelet-rich plasma was incubated with each drug for 45 min at 371C in the presence of 1 mM EGTA and 3H-5-HT uptake activity was estimated. EGTA-induced inhibition of 3H-5-HT uptake is expressed as % of the control (1 mM EGTA alone). c: After treatment with 1 mM EGTA at 371C for 60 min, each drug was applied with 2 mM CaC12. The mixtures were further incubated for 45 min and 3H-5-HT uptake activity was estimated. 3H-5-HT uptake activity increased by Ca 21 is expressed as % of the control (without drug). Each point represents the mean ±S.E.M. of four to six independent experiments. Significantly different from the control (*P<0.05, **P<0.01).
through their effect on GP IIb/IIIa function. It is generally accepted that the inhibitory regulation of the GP IIb/IIIa complex by EGTA is temperature-dependent (8) . Thus, dissociation of the GP IIb/IIIa complex occurs exclusively at 371C, but not at 20'C (9). Therefore, we determined if the effect of EGTA on 5-HT transport activity was also temperature-dependent.
As shown in Fig. 2 , treatment with EGTA at 20'C did not inhibit the 5-HT transport activity. This strongly suggested that EGTAinduced 5-HT transport inhibition might be elicited through its effect on the GP IIb/IIIa complex.
Intimate relationships between the cellular function of the GP IIb/IIIa complex and protein tyrosine kinase activity have been suggested in blood platelets (10, 11) . Interplay between protein tyrosine kinase and protein tyrosine phosphatase activities is assumed to control the phosphorylation status of proteins involved in signal transduction events. So, we examined whether protein tyrosine phosphorylation or dephosphorylation might be involved in the EGTA-induced 5-HT transport inhibition and/or its reversal by CaC12. Thus, we analyzed the effects of protein tyrosine phosphorylase inhibitors as well as those of protein tyrosine phosphatase inhibitors on 5-HT transport activity. Neither genistein, a competitive inhibitor of ATP binding to tyrosine kinase, nor thyrphostin A47, a competitive inhibitor of substrate binding to tyrosine kinase, affected 5-HT transport activity in the absence or presence of EGTA (Fig. 3: a and b) . However, both drugs significantly inhibited Ca 21 -induced restoration of 5-HT transport activity (Fig. 3c ). In contrast, PAO, a protein tyrosine phosphatase inhibitor, significantly augmented Ca 2+-induced restoration of 5-HT transport activity without affecting EGTA-induced 5-HT transport inhibition (Fig. 3: a, b and c) . It was reported that several tyrosine phosphorylated protein bands (52-62 kDa) were observed in unstimulated platelets (12) . Vostal et al. (13) suggested that homeostatic levels of Ca 21 in storage compartments favor tyrosine dephosphorylation of specific proteins and that the level of intracellular Ca2+ and stored Ca2+ appear to control tyrosine dephosphorylation antagonistically. Our present results might suggest that the Ca2+-induced restoration of 5-HT transport activity is mediated by tyrosine kinase activation. Thus, application of Ca 21 might cause functional restoration of the GP IIb/IIIa complex that had been inhibited by EGTA treatment, followed by activation of protein tyrosine phosphorylation and the restoration of 5-HT transport activity. At present, which tyrosine phosphorylated protein(s) might directly regulate 5-HT transport activity remains unclear. It has been reported that low molecular weight (21 kDa) GTP binding proteins, which serve as a substrate for tyrosine kinase, may mediated the function of GP IIb/IIIa in platelets (14) .
Recently, Helmeste and Tang (15) reported that tyrosine kinase regulated 5-HT transport into human blood platelets. They suggested that the effects of genistein, a tyrosine kinase inhibitor, might be mediated by an as yet illdefined non-Ca 2+-related mechanism. However, it should be kept in mind that 5-HT uptake inhibition of genistein was observed in the literature (15), while we found no inhibitory effect of genistein on 5-HT uptake into rabbit blood platelets (Fig. 3a) . It remains to be established whether the discrepancy is due to experimental conditions or whether it is related to the involvement of species variations.
It is conceivable that the GP IIb/IIIa complex, a platelet membrane integrin protein with Ca 2+ binding activity, might regulate 5-HT transport activity into blood platelets. An observation that pentamidine, a non-peptide antagonist of GP IIb/IIIa, significantly inhibited 5-HT transport activity into blood platelets (H. Nishio et al., unpublished observation) further supports the involvement of the GP IIb/IIIa complex in the regulation of 5-HT transport. Ca 21 chelation by EGTA might cause temperature-dependent dissociation of the GP IIb/IIIa complex, resulting in reduction of 5-HT transport activity. Rearrangement of the GP IIb/IIIa complex by replenishment of the Ca 2+ binding sites might ameliorate the EGTA-induced reduction of 5-HT uptake activity. This effect of Ca 2+ replenishment seems to be dependent, at least in part, on tyrosine kinase activity. The proposed mechanism for EGTA-induced inhibition and its restoration by Ca 21 will require further investigation, where identification of the substrate(s) for tyrosine phosphorylation involved in the 5-HT transport regulation would appear to be a most promising approach.
It was concluded that EGTA induced depletion of Ca 21 from its storage sites on the GP IIb/IIIa complex, indicating its dissociation and therefore its dysfunction, which might result in the inhibition of 5-HT transport activity. Replenishment of the Ca 2+ storage sites evoked recovery of the function of GP IIb/IIIa and restored the 5-HT transport activity in a protein tyrosine kinasedependent manner.
